ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Charles River Laboratories International Inc

Charles River Laboratories International Inc (CRL)

204.895
-4.96
( -2.36% )
Updated: 14:17:36

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
204.895
Bid
-
Ask
-
Volume
199,789
203.995 Day's Range 210.31
161.65 52 Week Range 275.00
Market Cap
Previous Close
209.85
Open
209.16
Last Trade
7
@
204.895
Last Trade Time
14:17:50
Financial Volume
$ 41,201,469
VWAP
206.2249
Average Volume (3m)
530,572
Shares Outstanding
51,511,687
Dividend Yield
-
PE Ratio
22.20
Earnings Per Share (EPS)
9.21
Revenue
4.13B
Net Profit
474.62M

About Charles River Laboratories International Inc

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic... Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services. Show more

Sector
Coml Physical, Biologcl Resh
Industry
Biological Pds,ex Diagnstics
Website
Headquarters
Wilmington, Delaware, USA
Founded
2010
Charles River Laboratories International Inc is listed in the Coml Physical, Biologcl Resh sector of the New York Stock Exchange with ticker CRL. The last closing price for Charles River Laboratories was $209.85. Over the last year, Charles River Laboratories shares have traded in a share price range of $ 161.65 to $ 275.00.

Charles River Laboratories currently has 51,511,687 shares outstanding. The market capitalization of Charles River Laboratories is $10.54 billion. Charles River Laboratories has a price to earnings ratio (PE ratio) of 22.20.

CRL Latest News

Charles River Laboratories Announces Strategic Lentiviral Vector Manufacturing Collaboration with Gates Institute at University of Colorado Anschutz Medical Campus

Lentiviral vector CDMO collaboration to support advanced cell therapies for hematological cancers Charles River Laboratories International, Inc. (NYSE: CRL) and the Gates Institute at the...

Charles River and Captain T Cell Announce Plasmid DNA and Viral Vector Manufacturing Alliance for Gene-Modified Cell Therapy

Leveraging CGT CDMO expertise to support T-cell immunotherapy clinical trial Charles River Laboratories International, Inc. (NYSE: CRL) and Captain T Cell, a spinoff from the renowned Max...

Charles River Laboratories, in Collaboration With MatTek Corporation, Awarded Grant from the Foundation for Chemistry Research and Initiatives to Advance Research Alternatives

Project will utilize an integrated approach to develop an in vitro alternative to inhalation toxicology studies Charles River Laboratories International, Inc. (NYSE: CRL) today announced a...

Charles River Laboratories Expands Access to CRADL® Contract Vivarium Space in Somerville

New turnkey research facility will provide AAALAC-accredited flexible vivarium space for Massachusetts biopharmaceutical hub Charles River Laboratories International, Inc. (NYSE: CRL) has...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-4.055-1.94065565925208.95213.63203.995461099210.43195505CS
4-12.905-5.92516069789217.8222.77203.995520625212.06794185CS
12-62.345-23.3292171831267.24268.81203.995530572227.21389815CS
26-31.855-13.4551214361236.75275201.01538733233.10644763CS
52-2.565-1.23638291719207.46275161.65512617216.53108393CS
156-161.885-44.136812258366.78460.21161.65507395247.28961137CS
26066.83548.4101115457138.06460.2195.58459000234.76284611CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
RGSRegis Corporation
$ 19.35
(281.66%)
38.12M
VLCNVolcon Inc
$ 8.61
(121.91%)
24.51M
CPOPPop Culture Group Company Ltd
$ 1.79
(55.65%)
31.68M
CNSPCNS Pharmaceuticals Inc
$ 3.1399
(40.80%)
8.94M
GRDIGRIID Infrastructure Inc
$ 1.91
(38.41%)
9.28M
XAIRBeyond Air Inc
$ 0.6538
(-51.21%)
8.91M
ALLRAllarity Therapeutics Inc
$ 0.22
(-31.03%)
26.78M
CRKNCrown Electrokinetics Corporation
$ 4.076
(-29.05%)
939.96k
UNCYUnicycive Therapeutics Inc
$ 0.5035
(-26.25%)
5.1M
NAASNaaS Technology Inc
$ 3.915
(-26.13%)
133.47k
NVDANVIDIA Corporation
$ 124.724
(5.60%)
301.96M
FFIEFaraday Future Intelligent Electric Inc
$ 0.2664
(-18.28%)
136.89M
GLYCGlycoMimetics Inc
$ 0.3286
(23.26%)
115.62M
SQQQProShares UltraPro Short QQQ
$ 8.435
(-2.93%)
89.1M
LRHCLa Rosa Holdings Corporation
$ 1.9609
(30.73%)
66.73M

CRL Discussion

View Posts
Monksdream Monksdream 4 months ago
CRL new 52 week high
👍️0
Monksdream Monksdream 4 months ago
CRL new 52 week high
Btw NAIC has my unqualified endorsement
👍️0
OncoJock OncoJock 9 months ago
This stock is featured prominently in the current issue of Better Investing magazine. Author of the article is Cy Lynch, chairman of the board of the National Association of Investors Corporation (NAIC).

Does anyone wish to discuss on this board?

-- OJ
👍️0
H2R H2R 2 years ago
Positive Outlook @ JP Morgan Presentation

1) The acquisition to continue to fuel growth



2) The 2022 outlook



https://ir.criver.com/static-files/f92d7468-bf01-4c5f-9bdb-7015940ab25a

Following the strategy, this looks good medium term/long term.

Best of luck in your investments!
👍️0
H2R H2R 2 years ago
Cell and Gene Therapy Acquisitions to Enhance End-to-End Offering for Developers

The promise offered by cell and gene therapies is currently tempered by the many challenges associated with developing them. Identifying a partner that can help guide, innovate, and navigate around them is a critical success factor for any program. Committed to this form of collaboration and support for our cell and gene therapy clients, we are pleased to announce the full integration of Cognate BioServices, Cobra Biologics, Vigene Biosciences, Hemacare, Cellero, Distributed Bio, Retrogenix into Charles River.

Today’s announcement marks another key milestone in our mission to invest in the tools, talent, and capacity to further the new frontier of regenerative medicine. With the benefit of a shared quality system, faster internal technical transfer, and process crossover between teams helping to reduce program bottlenecks and providing a seamless experience, we are now uniquely positioned to help our clients accelerate and achieve critical development goals from discovery to commercialization.

We have supported the development of 10 FDA-approved cell and gene therapies and have conducted more than 900 studies in this field over the past year. A key aim of this integration is to enhance client access to this wealth of scientific and regulatory experience as well as harnesses the power of our multidisciplinary bench of experts to problem solve in a collaborative manner every step of the way.

Learn about our end-to-end cell and gene therapy portfolio of services and products.

https://www.criver.com/insights/charles-river-integrates-cell-and-gene-therapy-acquisitions-enhance-end-end-offering-developers

Best of luck with your investments!
👍️0
H2R H2R 3 years ago
Two Divestitures: RMS Japan and CDMO Sweden

WILMINGTON, Mass.--(BUSINESS WIRE)--Oct. 12, 2021-- Charles River Laboratories International, Inc. (NYSE: CRL) announced that it has divested its Research Models and Services operations in Japan (RMS Japan) and its gene therapy CDMO site in Sweden (CDMO Sweden) in two separate transactions.
https://ir.criver.com/news-releases/news-release-details/charles-river-laboratories-announces-two-divestitures
👍️0
Glider549 Glider549 3 years ago
They prefer swinging for the fence.
👍️0
Skwerel Skwerel 3 years ago
Retail does not like stocks that will reliably make you rich
👍️0
Glider549 Glider549 3 years ago
Such a terrific stock, but no chatter.
Weird
👍️0
ValueInvestor15 ValueInvestor15 7 years ago
Evercore upgraded CRL to buy today. Fundamentals support rating change:

Upside Analysis
👍️0
stocktrademan stocktrademan 8 years ago
$CRL recent news/filings

bullish 80.08

## source: finance.yahoo.com

Tue, 15 Dec 2015 00:16:58 GMT ~ Here is What Hedge Funds Think About Cognex Corporation (CGNX)


read full: http://www.insidermonkey.com/blog/here-is-what-hedge-funds-think-about-cognex-corporation-cgnx-399706/
*********************************************************

Thu, 10 Dec 2015 11:06:37 GMT ~ CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits


read full: http://biz.yahoo.com/e/151210/crl8-k.html
*********************************************************

Tue, 08 Dec 2015 18:17:01 GMT ~ CHARLES RIVER LABORATORIES INTERNATIONAL INC Financials


read full: http://finance.yahoo.com/q/is?s=crl
*********************************************************

Tue, 08 Dec 2015 13:47:28 GMT ~ Charles River Laboratories Expands Long-Standing Collaboration with The Michael J. Fox Foundation for Parkinson’s Research

[at noodls] - WILMINGTON, Mass.--(BUSINESS WIRE)--Dec. 8, 2015-- Charles River Laboratories International, Inc. (NYSE: CRL) today announced a significant expansion of its work with small molecule LRRK2 inhibitors, funded ...

read full: http://www.noodls.com/view/0DA8DB56DBD68991529148737B3CF5BB6C53EE28
*********************************************************

Tue, 08 Dec 2015 13:30:00 GMT ~ Charles River Laboratories Expands Long-Standing Collaboration with The Michael J. Fox Foundation for Parkinson’s Research

[Business Wire] - Charles River Laboratories International, Inc. today announced a significant expansion of its work with small molecule LRRK2 inhibitors, funded by The Michael J. Fox Foundation for Parkinson’s Research , a leading organization working to support the diagnosis and treatment of Parkinson’s disease .

read full: http://finance.yahoo.com/news/charles-river-laboratories-expands-long-133000893.html
*********************************************************

$CRL charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com



$CRL company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/CRL/company-info
Ticker: $CRL
OTC Market Place: Not Available
CIK code: 0001100682
Company name: Charles River Laboratories International, Inc.
Incorporated In: DE, USA


$CRL share structure

## source: otcmarkets.com

Market Value: $3,733,616,447 a/o Dec 24, 2015
Shares Outstanding: 46,623,582 a/o Oct 16, 2015
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.01

$CRL extra dd links

Company name: Charles River Laboratories International, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/CRL/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/CRL/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=CRL+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=CRL+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=CRL+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/CRL/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/CRL/news - http://finance.yahoo.com/q/h?s=CRL+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/CRL/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/CRL/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/CRL/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/CRL/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/CRL/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/CRL/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/CRL/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/CRL/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=CRL+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/CRL
DTCC (dtcc.com): http://search2.dtcc.com/?q=Charles+River+Laboratories+International%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Charles+River+Laboratories+International%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Charles+River+Laboratories+International%2C+Inc.&x=0&y=0

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/CRL/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/CRL
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/CRL/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/CRL/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/CRL/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001100682&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/CRL/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/CRL/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/CRL/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/CRL/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=CRL&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=CRL
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/CRL/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=CRL+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=CRL+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=CRL
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=CRL
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=CRL+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/CRL/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=CRL+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/CRL.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=CRL
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/CRL/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/CRL/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/CRL/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/CRL/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/CRL
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/CRL
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/CRL:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=CRL
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=CRL



$CRL DD Notes ~ http://www.ddnotesmaker.com/CRL
👍️0
Penny Roger$ Penny Roger$ 12 years ago
~ Wednesday! $CRL ~ Q1 Earnings posted, pending or coming soon! In Charts and Links Below!

~ $CRL ~ Earnings expected on Wednesday *
Want more like this? Search Keyword: MACMONEY >>> http://tinyurl.com/MACMONEY <<<
One or more of many earnings sites has alerted this security has or will be posting earnings on or around the day of this message.








http://stockcharts.com/h-sc/ui?s=CRL&p=D&b=3&g=0&id=p88783918276&a=237480049




http://stockcharts.com/h-sc/ui?s=CRL&p=W&b=3&g=0&id=p54550695994



~ Google Finance: http://www.google.com/finance?q=CRL
~ Google Fin Options: hhttp://www.google.com/finance/option_chain?q=CRL#
~ Yahoo! Finance ~ Stats: http://finance.yahoo.com/q/ks?s=CRL+Key+Statistics
~ Yahoo! Finance ~ Profile: http://finance.yahoo.com/q/pr?s=CRL
Finviz: http://finviz.com/quote.ashx?t=CRL
~ BusyStock: http://busystock.com/i.php?s=CRL&v=2


<<<<<< http://www.earningswhispers.com/stocks.asp?symbol=CRL >>>>>>



http://investorshub.advfn.com/boards/post_prvt.aspx?user=251916

*If the earnings date is in error please ignore error. I do my best.
👍️0
Penny Roger$ Penny Roger$ 12 years ago
<<< $CRL Links! >>> ~ MAC's Quick DD Links without the charts.




PennyStockTweets ~ http://www.pennystocktweets.com/stocks/profile/CRL


OTC Markets Company Info ~ http://www.otcmarkets.com/stock/CRL/company-info
OTC Markets Charts ~ http://www.otcmarkets.com/stock/CRL/chart
OTC Markets Quote ~ http://www.otcmarkets.com/stock/CRL/quote
OTC Markets News ~ http://www.otcmarkets.com/stock/CRL/news
OTC Markets Financials ~ http://www.otcmarkets.com/stock/CRL/financials
OTC Markets Short Sales ~ http://www.otcmarkets.com/stock/CRL/short-sales
OTC Markets Insider Disclosure ~ http://www.otcmarkets.com/stock/CRL/insider-transactions
OTC Markets Research Reports ~ http://www.otcmarkets.com/stock/CRL/research


Google Finance Summary ~ http://www.google.com/finance?q=CRL
Google Finance News ~ http://www.google.com/finance/company_news?q=CRL
Google Finance Option chain ~ http://www.google.com/finance/option_chain?q=CRL
Google Finance Financials ~ http://www.google.com/finance?q=CRL&fstype=ii#
Google Finance Historical prices Daily ~ http://www.google.com/finance/historical?q=CRL
Google Finance Historical prices Weekly ~ http://www.google.com/finance/historical?q=CRL&histperiod=weekly#


Y! < Company >
Y! Profile ~ http://finance.yahoo.com/q/pr?s=CRL+Profile
Y! Key Stat's ~ http://finance.yahoo.com/q/ks?s=CRL+Key+Statistics
Y! Headlines ~ http://finance.yahoo.com/q/h?s=CRL+Headlines
Y! Summary ~ http://finance.yahoo.com/q?s=CRL
Y! Historical Prices ~ http://finance.yahoo.com/q/hp?s=CRL+Historical+Prices
Y! Order Book ~ http://finance.yahoo.com/q/ecn?s=CRL+Order+Book
Y! Message Boards ~ http://messages.finance.yahoo.com/mb/CRL
Y! Market Pulse ~ http://finance.yahoo.com/marketpulse/CRL
Y! Technical Analysis ~ http://finance.yahoo.com/q/ta?s=CRL+Basic+Tech.+Analysis
Y! < Analyst Coverage >
Y! Analyst Opinion ~ http://finance.yahoo.com/q/ao?s=CRL+Analyst+Opinion
Y! Analyst Estimates ~ http://finance.yahoo.com/q/ae?s=CRL+Analyst+Estimates
Y! Research Reports ~ http://finance.yahoo.com/q/rr?s=CRL+Research+Reports
Y! Star Analysts ~ http://finance.yahoo.com/q/sa?s=CRL+Star+Analysts
Y! < Ownership >
Y! Major Holders ~ http://finance.yahoo.com/q/mh?s=CRL+Major+Holders
Y! Insider Transactions ~ http://finance.yahoo.com/q/it?s=CRL+Insider+Transactions
Y! Insider Roster ~ http://finance.yahoo.com/q/ir?s=CRL+Insider+Roster
Y! < Financials >
Y! Income Statement ~ http://finance.yahoo.com/q/is?s=CRL+Income+Statement&annual
Y! Balance Sheet ~ http://finance.yahoo.com/q/bs?s=CRL+Balance+Sheet&annual
Y! Cash Flow ~ http://finance.yahoo.com/q/cf?s=CRL+Cash+Flow&annual


FINVIZ ~ http://finviz.com/quote.ashx?t=CRL&ty=c&ta=0&p=d


Investorshub Trades ~ http://ih.advfn.com/p.php?pid=trades&symbol=CRL
Investorshub Board Search ~ http://investorshub.advfn.com/boards/getboards.aspx?searchstr=CRL
Investorshub PostStream ~ http://investorshub.advfn.com/boards/poststream.aspx?ticker=CRL
Investorshub Messages ~ http://investorshub.advfn.com/boards/msgsearch.aspx?SearchStr=CRL
Investorshub Videos ~ http://ih.advfn.com/p.php?pid=ihvse&ihvqu=CRL
Investorshub News ~ http://ih.advfn.com/p.php?pid=news&btn=s_ok&ctl00%24sb3%24tbq1=Get+Quote&as_values_IH=&ctl00%24sb3%24stb1=Search+iHub&symbol=CRL&s_ok=OK&from_month=3&from_day=15&from_year=2012&order=desc&selsrc%5B%5D=prnca&selsrc%5B%5D=prnus&selsrc%5B%5D=zacks&selsrc%5B%5D=money2&selsrc%5B%5D=djn&selsrc%5B%5D=bw&selsrc%5B%5D=globe&selsrc%5B%5D=edgar&selsrc%5B%5D=mwus&force=1&last_ts=1331855999&p_n=1&p_count=&p_ts=1331794260


CandlestickChart ~ http://www.candlestickchart.com/cgi/chart.cgi?symbol=CRL&exchange=US


Barchart Quote ~ http://barchart.com/quotes/stocks/CRL?
Barchart Detailed Quote ~ http://barchart.com/detailedquote/stocks/CRL
Barchart Options Quotes ~ http://barchart.com/options/stocks/CRL
Barchart Technical Chart ~ http://barchart.com/charts/stocks/CRL&style=technical
Barchart Interactive Chart ~ http://barchart.com/charts/stocks/CRL&style=interactive
Barchart Technical Analysis ~ http://barchart.com/technicals/stocks/CRL
Barchart Trader's Cheat Sheet ~ http://barchart.com/cheatsheet.php?sym=CRL
Barchart Barchart Opinion ~ http://barchart.com/opinions/stocks/CRL
Barchart Snapshot Opinion ~ http://barchart.com/snapopinion/stocks/CRL
Barchart News Headlines ~ http://barchart.com/news/stocks/CRL
Barchart Profile ~ http://barchart.com/profile//CRL
Barchart Key Statistics ~ http://barchart.com/profile.php?sym=CRL&view=key_statistics


OTC: American Bulls ~ http://www.americanbulls.com/StockPage.asp?CompanyTicker=CRL&MarketTicker=OTC&TYP=S
NASDAQ: American Bulls ~ http://www.americanbulls.com/StockPage.asp?CompanyTicker=CRL&MarketTicker=NASD&TYP=S
NYSE: American Bulls ~ http://www.americanbulls.com/StockPage.asp?CompanyTicker=CRL&MarketTicker=NYSE&Typ=S


Marketwatch Profile ~ http://www.marketwatch.com/investing/stock/CRL/profile
Marketwatch Analyst Estimates ~ http://www.marketwatch.com/investing/stock/CRL/analystestimates
Marketwatch Historical Quotes ~ http://www.marketwatch.com/investing/stock/CRL/historical
Marketwatch Financials ~ http://www.marketwatch.com/investing/stock/CRL/financials
Marketwatch Overview ~ http://www.marketwatch.com/investing/stock/CRL
Marketwatch SEC Filings ~ http://www.marketwatch.com/investing/stock/CRL/secfilings
Marketwatch Picks ~ http://www.marketwatch.com/investing/stock/CRL/picks
Marketwatch Hulbert ~ http://www.marketwatch.com/investing/stock/CRL/hulbert
Marketwatch Insider Actions ~ http://www.marketwatch.com/investing/stock/CRL/insideractions
Marketwatch Options ~ http://www.marketwatch.com/investing/stock/CRL/options
Marketwatch Charts ~ http://www.marketwatch.com/investing/stock/CRL/charts
Marketwatch News ~ http://bigcharts.marketwatch.com/news/symbolsearch/symbolnews.asp?news=markadv&symb=CRL&sid=1795093&framed=False


The Lion ~ http://thelion.com/bin/aio_msg.cgi?cmd=search&msg=&si=1&tw=1&tt=1&rb=1&ih=1&fo=1&iv=1&yf=1&sa=1&fb=1&gg=1&symbol=CRL


Search NYSE ~ http://www.nyse.com/about/listed/lcddata.html?ticker=CRL


StockTA ~ http://www.stockta.com/cgi-bin/analysis.pl?symb=CRL&num1=567&cobrand=&mode=stock


StockHouse ~ http://www.stockhouse.com/financialtools/sn_overview.aspx?qm_symbol=CRL
StockHouse Delayed LII ~ http://www.stockhouse.com/financialtools/sn_level2.aspx?qm_page=46140&qm_symbol=CRL


AlphaTrade ~ http://tools.alphatrade.com/index.php?t1=mc_quote_module&t2=mc_quote_module2&t3=historical&template=historical2html&sym=CRL&client_id=2740&a_width=680&a_height=1000&language=english&showVol=1&chtype=8


Reuters ~ http://www.reuters.com/finance/stocks/companyOfficers?symbol=CRL.PK&WTmodLOC=C4-Officers-5


StockWatch ~ http://www.stockwatch.com/Quote/Detail.aspx?symbol=CRL®ion=U


Search NASDAQ ~ http://www.nasdaq.com/symbol/CRL
NASDAQ Divy History ~ http://www.nasdaq.com/symbol/CRL/dividend-history
NASDAQ Short Interest ~ http://www.nasdaq.com/symbol/CRL/short-interest
NASDAQ Institutional Ownership ~ http://www.nasdaq.com/symbol/CRL/institutional-holdings
NASDAQ FlashQuotes ~ http://www.nasdaq.com/aspx/flashquotes.aspx?symbol=CRL&selected=CRL
NASDAQ InfoQuotes ~ http://www.nasdaq.com/aspx/infoquotes.aspx?symbol=CRL&selected=CRL
NASDAQ After Hours Quote ~ http://www.nasdaq.com/symbol/CRL/after-hours
NASDAQ Pre-Market Quote ~ http://www.nasdaq.com/symbol/CRL/premarket
NASDAQ Historical Quote ~ http://www.nasdaq.com/symbol/CRL/historical
NASDAQ Option Chain ~ http://www.nasdaq.com/symbol/CRL/option-chain
NASDAQ Company Headlines ~ http://www.nasdaq.com/symbol/CRL/news-headlines
NASDAQ Press Releases ~ http://www.nasdaq.com/symbol/CRL/news-headlines
NASDAQ Sentiment ~ http://www.nasdaq.com/symbol/CRL/sentiment
NASDAQ Analyst Summary ~ http://www.nasdaq.com/symbol/CRL/analyst-research
NASDAQ Guru Analysis~ http://www.nasdaq.com/symbol/CRL/guru-analysis
NASDAQ Stock Report ~ http://www.nasdaq.com/symbol/CRL/stock-report
NASDAQ Competitors ~ http://www.nasdaq.com/symbol/CRL/competitors
NASDAQ Stock Consultant ~ http://www.nasdaq.com/symbol/CRL/stock-consultant
NASDAQ Stock Comparison ~ http://www.nasdaq.com/symbol/CRL/stock-comparison
NASDAQ Call Transcripts ~ http://www.nasdaq.com/symbol/CRL/call-transcripts
NASDAQ Annual Reports ~ http://www.nasdaq.com/aspx/annualreport.aspx?symbol=CRL&selected=CRL
NASDAQ Financials ~ http://www.nasdaq.com/symbol/CRL/financials
NASDAQ Revenue & Earnings Per Share (EPS) ~ http://www.nasdaq.com/symbol/CRL/revenue-eps
NASDAQ SEC Filings ~ http://www.nasdaq.com/symbol/CRL/sec-filings
NASDAQ Ownership Summary ~ http://www.nasdaq.com/symbol/CRL/ownership-summary
NASDAQ Institutional Ownership ~ http://www.nasdaq.com/symbol/CRL/institutional-holdings
NASDAQ (SEC Form 4) ~
--------- All Trades ~ http://www.nasdaq.com/symbol/CRL/insider-trades
--------- Buys ~ http://www.nasdaq.com/symbol/CRL/insider-trades/buys
--------- Sells ~ http://www.nasdaq.com/symbol/CRL/insider-trades/sells


The Motley Fool ~ http://caps.fool.com/Ticker/CRL.aspx
The Motley Fool Earnings/Growth ~ http://caps.fool.com/Ticker/CRL/EarningsGrowthRates.aspx?source=itxsittst0000001
The Motley Fool Ratios ~ http://caps.fool.com/Ticker/CRL/Ratios.aspx?source=itxsittst0000001
The Motley Fool Stats ~ http://caps.fool.com/Ticker/CRL/Stats.aspx?source=icasittab0000006
The Motley Fool Historical ~ http://caps.fool.com/Ticker/CRL/Historical.aspx?source=icasittab0000004
The Motley Fool Scorecard ~ http://caps.fool.com/Ticker/CRL/Scorecard.aspx?source=icasittab0000003
The Motley Fool Statements ~ http://caps.fool.com/Ticker/CRL/Statements.aspx?source=icasittab0000009


MSN Money ~ http://investing.money.msn.com/investments/stock-ratings?symbol=CRL


YCharts ~ http://ycharts.com/companies/CRL
YCharts Performance ~ http://ycharts.com/companies/CRL/performance
YCharts Dashboard ~ http://ycharts.com/companies/CRL/dashboard


InsideStocks Opinion ~ http://www.insidestocks.com/texpert.asp?sym=CRL&code=XDAILY
InsideStocks Profile ~ http://www.insidestocks.com/profile.asp?sym=CRL&code=XDAILY
InsideStocks Quote ~ http://www.insidestocks.com/quote.asp?sym=CRL&code=XDAILY
InsideStocks Projection ~ http://charts3.barchart.com/procal.asp?sym=CRL


Zacks Quote ~ http://www.zacks.com/stock/quote/CRL
Zacks Estimates ~ http://www.zacks.com/research/report.php?type=estimates&t=CRL
Zacks Company Reports ~ http://www.zacks.com/research/report.php?type=report&t=CRL


Knobias ~ http://knobias.10kwizard.com/files.php?sym=CRL


StockScores ~ http://www.stockscores.com/quickreport.asp?ticker=CRL


Trade-Ideas ~ http://www.trade-ideas.com/StockInfo/CRL/HOT_TOPIC.html


Morningstar ~ http://performance.morningstar.com/stock/performance-return.action?region=USA&t=CRL&culture=en-US
Morningstar Shareholders ~ http://investors.morningstar.com/ownership/shareholders-overview.html?t=CRL®ion=USA&culture=en-us
Morningstar Transcripts~ http://www.morningstar.com/earnings/NoTranscript.aspx?t=CRL®ion=USA
Morningstar Key Ratios ~ http://financials.morningstar.com/ratios/r.html?t=CRL®ion=USA&culture=en-US
Morningstar Executive Compensation ~ http://insiders.morningstar.com/trading/executive-compensation.action?t=CRL®ion=USA&culture=en-us
Morningstar Valuation ~ http://financials.morningstar.com/valuation/price-ratio.html?t=CRL®ion=USA&culture=en-us


CCBN (Thompson Reuters) ~ http://ccbn.aol.com/company.asp?client=aol&ticker=CRL


TradingMarkets ~ http://pr.tradingmarkets.com/?lid=leftPRbox&sym=CRL


OTCBB ~ http://www.otcbb.com/asp/SiteSearch.asp?Criteria=CRL&searcharea=e&image1.x=0&image1.y=0


Insidercow ~ http://www.insidercow.com/history/company.jsp?company=CRL&B1=Search%21


Forbes News ~ http://search.forbes.com/search/find?tab=searchtabgeneraldark&MT=CRL
Forbes Press Releases ~ http://search.forbes.com/search/find?&start=1&tab=searchtabgeneraldark&MT=CRL&pub=businesswire,prnewswire&searchResults=pressRelease&tag=pr&premium=on
Forbes Web ~ http://search.forbes.com/search/web?MT=UNGS&start=1&max=10&searchResults=web&tag=web&sort=null


YouTube Symbol Search ~ http://www.youtube.com/results?search_query=CRL


Buy-Ins ~ http://www.buyins.net/tools/symbol_stats.php?sym=CRL


Quotemedia ~ http://www.quotemedia.com/results.php?qm_page=47556&qm_symbol=CRL


Earnings Whispers ~ http://www.earningswhispers.com/stocks.asp?symbol=CRL

Bloomberg Snapshot ~ http://investing.businessweek.com/research/stocks/snapshot/snapshot.asp?ticker=CRL
Bloomberg People ~ http://investing.businessweek.com/research/stocks/people/people.asp?ticker=CRL

Financial Times ~ http://markets.ft.com/Research/Markets/Tearsheets/Summary?s=CRL

Investorpoint ~ http://www.investorpoint.com/ enter "CRL" and click search.

Hotstocked ~ http://www.hotstocked.com/ enter "CRL" and click search.

Raging Bull ~ http://ragingbull.quote.com/mboard/boards.cgi?board=CRL

Hoovers ~ http://www.hoovers.com/search/company-search-results/100003765-1.html?type=company&term=CRL

DD Machine ~ http://www.ddmachine.com/default.asp?m=stocktool_frame.asp?symbol=CRL

SEC Form 4 ~ http://www.secform4.com/insider/showhistory.php?cik=CRL

OTCBB Pulse ~ http://www.otcbbpulse.com/cgi-bin/pulsequote.cgi?symbol=CRL

Failures To Deliver ~ http://failurestodeliver.com/default2.aspx enter "CRL" and click search.

http://www.coordinatedlegal.com/SecretaryOfState.html

http://regsho.finra.org/regsho-Index.html

http://www.shortsqueeze.com/?symbol=CRL&submit=Short+Quote%99



DTCC (PENSON/TDA) Check - (otc and pinks) - Note ~ I did not check for this chart blast. However, I try and help you to do so with the following links.
IHUB DTCC BOARD SEARCH #1 http://investorshub.advfn.com/boards/msgsearchbyboard.aspx?boardID=18682&srchyr=2011&SearchStr=CRL
IHUB DTCC BOARD SEARCH #2: http://investorshub.advfn.com/boards/msgsearchbyboard.aspx?boardID=14482&srchyr=2011&SearchStr=CRL
Check those searches for recent CRL mentions. If CRL is showing up on older posts and not on new posts found in link below, The DTCC issues may have been addressed and fixed. Always call the broker if your security turns up on any DTCC/PENSON list.
http://investorshub.advfn.com/boards/msgsearchbyboard.aspx?boardID=18682&srchyr=2011&SearchStr=Complete+list
For a complete list see the pinned threads at the top here ---> http://tinyurl.com/TWO-OLD-FARTS



MACDlinks
👍️0
Penny Roger$ Penny Roger$ 12 years ago
~ Wednesday! $CEVA ~ Q1 Earnings posted, pending or coming soon! In Charts and Links Below!

~ $CEVA ~ Earnings expected on Wednesday *
Want more like this? Search Keyword: MACMONEY >>> http://tinyurl.com/MACMONEY <<<
One or more of many earnings sites has alerted this security has or will be posting earnings on or around the day of this message.








http://stockcharts.com/h-sc/ui?s=CEVA&p=D&b=3&g=0&id=p88783918276&a=237480049




http://stockcharts.com/h-sc/ui?s=CEVA&p=W&b=3&g=0&id=p54550695994



~ Google Finance: http://www.google.com/finance?q=CEVA
~ Google Fin Options: hhttp://www.google.com/finance/option_chain?q=CEVA#
~ Yahoo! Finance ~ Stats: http://finance.yahoo.com/q/ks?s=CEVA+Key+Statistics
~ Yahoo! Finance ~ Profile: http://finance.yahoo.com/q/pr?s=CEVA
Finviz: http://finviz.com/quote.ashx?t=CEVA
~ BusyStock: http://busystock.com/i.php?s=CEVA&v=2


<<<<<< http://www.earningswhispers.com/stocks.asp?symbol=CEVA >>>>>>



http://investorshub.advfn.com/boards/post_prvt.aspx?user=251916

*If the earnings date is in error please ignore error. I do my best.
👍️0
Penny Roger$ Penny Roger$ 12 years ago
~ Monday! $CRL ~ Earnings posted, pending or coming soon! In Charts and Links Below!

~ $CRL ~ Earnings expected on Monday *
Want more like this? Search Keyword: MACMONEY >>> http://tinyurl.com/MACMONEY <<<
One or more of many earnings sites has alerted this security has or will be posting earnings on or around the day of this message.








http://stockcharts.com/h-sc/ui?s=CRL&p=D&b=3&g=0&id=p88783918276&a=237480049




http://stockcharts.com/h-sc/ui?s=CRL&p=W&b=3&g=0&id=p54550695994



~ Google Finance: http://www.google.com/finance?q=CRL
~ Google Fin Options: hhttp://www.google.com/finance/option_chain?q=CRL#
~ Yahoo! Finance ~ Stats: http://finance.yahoo.com/q/ks?s=CRL+Key+Statistics
~ Yahoo! Finance ~ Profile: http://finance.yahoo.com/q/pr?s=CRL
Finviz: http://finviz.com/quote.ashx?t=CRL
~ BusyStock: http://busystock.com/i.php?s=CRL&v=2


<<<<<< http://www.earningswhispers.com/stocks.asp?symbol=CRL >>>>>>



http://investorshub.advfn.com/boards/post_prvt.aspx?user=251916

*If the earnings date is in error please ignore error. I do my best.
👍️0
Penny Roger$ Penny Roger$ 12 years ago
~ $CRL ~ Earnings posted, pending or coming soon! In Charts and Links Below!

~ $CRL ~ Earnings expected on Monday *
This Week In Earnings: Earnings are coming or are already posted! This is what the charts look like! If you play the earnings these posts can be very helpful to you!
Want more like this? Search Keyword: MACMONEY >>> http://tinyurl.com/MACMONEY <<<
One or more of many earnings sites has alerted this security has or will be posting earnings on or around the day of this message.








http://stockcharts.com/h-sc/ui?s=CRL&p=D&b=3&g=0&id=p88783918276&a=237480049




http://stockcharts.com/h-sc/ui?s=CRL&p=W&b=3&g=0&id=p54550695994



~ Barchart: http://barchart.com/quotes/stocks/CRL?
~ OTC Markets: http://www.otcmarkets.com/stock/CRL/company-info
~ Google Finance: http://www.google.com/finance?q=CRL
~ Google Fin Options: hhttp://www.google.com/finance/option_chain?q=CRL#
~ Yahoo! Finance ~ Stats: http://finance.yahoo.com/q/ks?s=CRL+Key+Statistics
~ Yahoo! Finance ~ Profile: http://finance.yahoo.com/q/pr?s=CRL
Finviz: http://finviz.com/quote.ashx?t=CRL
~ BusyStock: http://busystock.com/i.php?s=CRL&v=2
~ CandlestickChart: http://www.candlestickchart.com/cgi/chart.cgi?symbol=CRL&exchange=US
~ Investorshub Trades: http://ih.advfn.com/p.php?pid=trades&symbol=CRL
~ Investorshub Board Search: http://investorshub.advfn.com/boards/getboards.aspx?searchstr=CRL
~ Investorshub PostStream Search: http://investorshub.advfn.com/boards/poststream.aspx?ticker=CRL
~ Investorshub Goodies Search: http://investorshub.advfn.com/boards/msgsearchbyboard.aspx?boardID=18582&srchyr=2011&SearchStr=CRL
~ Investorshub Message Search: http://investorshub.advfn.com/boards/msgsearch.aspx?SearchStr=CRL
~ MarketWatch: http://www.marketwatch.com/investing/stock/CRL/profile
~ E-Zone Chart: http://www.windchart.com/ezone/signals/?symbol=CRL
~ 5-Min Wind: http://www.windchart.com/stockta/analysis?symbol=CRL
~ 10-Min Wind: http://www.windchart.com/stockta/analysis?symbol=CRL&size=l&frequency=10&color=g
~ 30-Min Wind: http://www.windchart.com/stockta/analysis?symbol=CRL&size=l&frequency=30&color=g
~ 60-Min Wind: http://www.windchart.com/stockta/analysis?symbol=CRL&size=l&frequency=60&color=g


http://investorshub.advfn.com/boards/post_prvt.aspx?user=251916

*If the earnings date is in error please ignore error. I do my best.
👍️0
finless139 finless139 13 years ago
Anyone hear that they sold their imaging unit in Ann Arbor?
👍️0
Stock Stock 14 years ago
Charles River to buy WuXi Pharma for $1.6 billion

On Monday April 26, 2010, 2:13 pm
By Esha Dey

BANGALORE (Reuters) - U.S. clinical research company Charles River Laboratories International (NYSE:CRL - News) agreed to buy Chinese rival WuXi PharmaTech (NYSE:WX - News) for $1.6 billion to expand its presence in China and deepen its expertise in drug-discovery services.

Charles River is focused on pre-clinical and early-stage research, while Shanghai-based WuXi -- one of the biggest Chinese clinical research organizations (CRO) -- is active in drug chemistry, such as making molecules to synthesize a drug.

Charles River will offer $21.25 per WuXi American Depositary Share in cash and stock, representing a premium of 28 percent to WuXi's Friday closing price.

Each WuXi ADS will get $11.25 in cash and $10 of Charles River common stock, the companies said in a joint statement.

However, WuXi shares were trading up only 19 percent at $19.70 in morning trade Monday on the New York Stock Exchange, indicating investor skepticism about the deal.

Charles River shares fell 14 percent to $34.09 on the New York Stock Exchange on concerns of the U.S.-based company's ability to execute and integrate such a big deal.

Robert W. Baird analyst Eric Coldwell said the deal value was "a bit aggressive," adding that given the disparate geographies, cultures and services, he sees more than a modest risk in integration.

"We expect some, if not majority of WuXi shareholders, will sell their positions on WuXi post merger given the likely slower growth of the combined entity versus WuXi standalone," said Susquehanna Financial Group analyst Ding Ding in a note.

LONG-TERM GAINS

Analysts broadly agree that the deal made sense thematically due to WuXi's exposure in the fast-growing Chinese market and limited overlap between the service offerings of the two firms. Even though short-term risks remain, the deal can prove to be beneficial in the long term.

"We are increasingly convinced China is becoming a very important market for pharma and therefore view the combination as a long-term positive for Charles River, given we believe WuXi is the leading player and brand name in China," William Blair and Co analyst John Kreger said.

Large, concentrated populations, access to patients where certain diseases -- like malaria -- are widespread and an opportunity to run trials in markets with a rising demand for medicines are what make markets like China attractive destinations for the outsourced drug research industry.

"Outsourcing is going global and China is increasingly important, though Chinese firms still face headwinds, which Charles River's global brand and image could mitigate," Baird's Coldwell said.

Research service providers to drugmakers have seen their growth rate slow over the past one year, pushing them to look for newer strategies like increased specialization in specific areas and tap faster growth areas like the emerging markets.

Monday's deal is a proof of a growing trend within the CRO industry that is seeing bigger U.S. players specialize more to offer high-end services to their clients, with pre-clinical and early-stage focused Charles River and Covance Inc (NYSE:CVD - News) investing heavily in drug discovery services.

Thus Shanghai-based WuXi is a strategic fit for Charles River that is trying to expand into more upstream services in the drug research pathway.

"(The deal would) give Charles River medicinal development capabilities, which is currently outside of Charles River's core competency," Deutsche Bank analyst Ross Muken said.

DEAL TO BOOST MARGINS

Charles River expects the deal to improve its margins, it said on a conference call with analysts.

For 2009, WuXi had an adjusted gross margin of 42.3 percent, while Charles River had a gross margin of 35.7 percent.

Charles River has received a financing commitment for a $1.25 billion credit facility from JP Morgan Chase and Bank of America-Merrill Lynch.

The combined company will be led by Charles River Chief Executive James Foster, while WuXi PharmaTech's Ge Li will become corporate executive vice president. Li will also be the president of global discovery and China services, a new segment.

Q1 PROFIT FALLS

Separately, Charles River reported a lower first-quarter profit, impacted by weak sales volume and higher costs related to the company's enterprise resource planning initiative.

On a non-GAAP basis, net income was $29.3 million, or 45 cents a share, compared with $38.2 million for the same period in 2009, a fall of 23.2 percent.

Quarterly net sales fell 1.4 percent to $297.3 million.

Analysts on average expected first-quarter earnings of 47 cents a share, excluding special items, on sales of $296.8 million, according to Thomson Reuters I/B/E/S.

Charles River was one of the worst affected among its peers and had a tough run in 2009 as drug developers tended to halt early-stage research to conserve cash rather than stopping the development of late-stage drugs that could reach the market faster.

However, the company is finally seeing early signs of demand stabilizing and Baird's Coldwell said he expects to see modest improvement in bookings and significant decreases in cancellations through 2010.

On the call, the company said it sees 2010 sales of $1.51 billion to $1.56 billion for the combined company and expects a 2 percent to 3 percent rise in second-quarter sales from the first quarter.

(Additional reporting by Sakthi Prasad; Editing by Muralikumar Anantharaman, Sharon Lindores, Unnikrishnan Nair, Gopakumar Warrier)

👍️0

Your Recent History

Delayed Upgrade Clock